Trials / Not Yet Recruiting
Not Yet RecruitingNCT06570265
RES-SAFE (Resorption, Safety, and Efficacy of Absorbable Collagen Membrane)
Evaluation of Resorption, Safety, and Efficacy of Absorbable Collagen Membrane in Preventing Significant Bone Loss Following GBR (Guided Bone Regeneration) Procedure.
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Hyundai Bioland Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The clinical study aims to assess the long-term safety and efficacy of the interventional medical device. The clinical study will enrol up to 50 patients aged 18 years and older, who meet specific inclusion and exclusion criteria designed to ensure patient safety and reliable data collection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | GBR membrane | GBR procedure is a technique often used in conjunction with dental implants to enhance the success and stability of the implant. This technique involves using barrier membranes to protect the bone graft or defect site from the rapid proliferation of surrounding soft tissues. In this clinical investigation resorbable, collagen membrane will be used. |
Timeline
- Start date
- 2024-12-16
- Primary completion
- 2026-05-16
- Completion
- 2026-06-30
- First posted
- 2024-08-26
- Last updated
- 2024-08-26
Source: ClinicalTrials.gov record NCT06570265. Inclusion in this directory is not an endorsement.